Journal of Diabetes Research (Jan 2023)

Low Total Testosterone Levels in Men with Newly Diagnosed Early-Onset Type 2 Diabetes: A Cross-Sectional Study in China

  • Yun Hu,
  • Lu Yuan,
  • Yu-jie Bao,
  • Ying Wang,
  • Ting-ting Cai,
  • Jian-hua Ma,
  • Bo Ding

DOI
https://doi.org/10.1155/2023/2082940
Journal volume & issue
Vol. 2023

Abstract

Read online

Objective. There is a bidirectional interaction between circulating testosterone and blood glucose levels. We aim to investigate the testosterone levels in men with early-onset type 2 diabetes (T2DM). Methods. A total of 153 drug naive men with T2DM were enrolled in the study. Early- (n=63) and late-onset (n=90) T2DM was classified according to age 40 years old. Clinical characteristics and plasma for biochemical criterions were collected. Gonadal hormones were measured using chemiluminescent immunometric assay. The concentrations of 3β- and 17β-HSD were determined using ELISA. Results. Compared with men with late-onset T2DM, those with early-onset T2DM had lower serum total testosterone (TT), sex hormone-binding globulin (SHBG), and FSH, but higher dehydroepiandrosterone sulfate (DHEA-S) level (p<0.05). The mediating effect analysis showed that the decreased TT levels in patients with early-onset T2DM were associated with the higher HbA1c, BMI, and triglyceride in these patients (both p<0.05). The early-onset of T2DM directly correlated with increased DHEA-S (both p<0.01). The 3β-HSD concentration in the early-onset T2DM group was lower than that in the late-onset T2DM group (11.07±3.05 vs. 12.40±2.72 pg/mL, p=0.048) and was positively correlated with fasting C-peptide, while negatively correlated with HbA1c and fasting glucagon (p all < 0.05). Conclusions. Patients with early-onset T2DM showed inhibition of conversion from DHEA to testosterone, which may attribute to the low level of 3β-HSD and high blood glucose in these patients.